Physician
Collierville Pediatrics, LLC
Collierville Pediatrics, LLC was paid $3.08M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoCOLLIERVILLE PEDIATRICS, LLC
COLLIERVILLE, TN 38017
COLLIERVILLE, TN 38017
33aNPI1326229345assigned 11/19/2007
33bProvider typePediatrics Physician
28Total paid$3.08M
24GClaims154,103
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#38 of 333
Median peer was paid$139K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,588 | $289K | |
| 2019 | 18,410 | $409K | |
| 2020 | 17,534 | $370K | |
| 2021 | 24,649 | $475K | |
| 2022 | 34,471 | $603K | |
| 2023 | 28,454 | $560K | |
| 2024incomplete | 15,997 | $369K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 16,540 | 12,606 | $610K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 7,920 | 5,880 | $438K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 10,163 | 7,802 | $377K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 5,198 | 4,384 | $319K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.1% | 4,489 | 3,641 | $281K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 8.1% | 10,081 | 8,340 | $249K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.5% | 3,028 | 2,543 | $168K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 2,459 | 1,890 | $165K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 2,398 | 1,805 | $71K |
| 96160 | 1.0% | 3,268 | 2,426 | $32K | |
| 99174 | <1% | 3,110 | 2,620 | $30K | |
| 92551 | <1% | 4,301 | 3,186 | $27K |
62 more codes
| 96127 | <1% | 6,944 | $26K | |
| 99173 | <1% | 5,452 | $25K | |
| 96161 | <1% | 2,175 | $23K | |
| 85018 | <1% | 9,964 | $21K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,877 | $20K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,859 | $17K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 340 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 344 | $15K |
| 36416 | <1% | 10,243 | $14K | |
| 90651 | <1% | 565 | $13K | |
| 83655 | <1% | 1,170 | $12K | |
| 99408 | <1% | 3,106 | $12K | |
| 99381 | <1% | 191 | $11K | |
| 90686 | <1% | 2,000 | $8K | |
| 0002A | <1% | 165 | $6K | |
| 0001A | <1% | 183 | $6K | |
| 90716 | <1% | 1,170 | $5K | |
| 90461 | <1% | 5,451 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 524 | $5K |
| 90677 | <1% | 370 | $5K | |
| 99401 | <1% | 451 | $4K | |
| 0071A | <1% | 109 | $4K | |
| 90670 | <1% | 2,678 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 59 | $4K |
| 90734 | <1% | 449 | $3K | |
| 0072A | <1% | 81 | $3K | |
| 90707 | <1% | 1,141 | $3K | |
| 3008F | <1% | 9,607 | $2K | |
| 0012A | <1% | 49 | $2K | |
| 99383 | <1% | 33 | $2K | |
| 0011A | <1% | 51 | $2K | |
| 90633 | <1% | 1,137 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 24 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 921 | $972.14 |
| 90715 | <1% | 193 | $944.17 | |
| 90680 | <1% | 1,878 | $845.77 | |
| 86328 | <1% | 25 | $746.83 | |
| 90723 | <1% | 2,312 | $739.50 | |
| 0003A | <1% | 21 | $680.00 | |
| 90696 | <1% | 258 | $664.93 | |
| 80061 | Lipid panel | <1% | 316 | $510.51 |
| 90632 | <1% | 461 | $470.39 | |
| 81002 | <1% | 197 | $422.00 | |
| 90672 | <1% | 51 | $380.04 | |
| 90620 | <1% | 65 | $275.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 199 | $262.41 |
| 80053 | Comprehensive metabolic panel | <1% | 271 | $224.58 |
| 90647 | <1% | 1,426 | $104.41 | |
| 90648 | <1% | 1,315 | $102.26 | |
| 90658 | <1% | 12 | $52.72 | |
| 87081 | <1% | 25 | $44.26 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 81 | $38.42 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $36.89 |
| 90656 | <1% | 22 | $26.40 | |
| 90700 | <1% | 169 | $16.15 | |
| 91300 | <1% | 479 | $0.73 | |
| 91307 | <1% | 201 | $0.23 | |
| 91301 | <1% | 119 | $0.14 | |
| 90685 | 0% | 30 | $0.00 | |
| 99188 | 0% | 16 | $0.00 | |
| 90710 | 0% | 14 | $0.00 | |
| 90733 | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVENKATARAMAN, JAYA (MD/PRESIDENT)